natcopharma.co.in

GENERAL
META
HTML
LINK ANALYSIS
SERVER
IP

Natcopharma.co.in receives any estimated 1,619 unique visitors and 2,188 unique page views per day. Revenue gained from these much visits may be $1 per day from various advertising sources. The estimated worth of site is $449. Similarweb global rank is 1,504,163. Maximum no. of users comes from .

Vkms - NOC is ISP, hosted on IP 120.138.8.108 in Country India.

Website Age n/a
Alexa Rank no-data
Country India
IP Address 120.138.8.108

META INFORMATION

Title

Natco Pharma |

Description

Keywords

Content Type

utf-8

No	Meta Name	Value
1	viewport	width=device-width, initial-scale=1

GENERAL HTML INFORMATION

Type	Status
HTML 5
Responsive Website

HTML SIZE INFORMATION

Text / Code Ratio 11.15 %

natcopharma.co.in has a website text/code ratio of 11.15 %. Search engine crawlers tend to not pick up pages with inadequate content.

IMPORTANT HTML TAGS AND COUNTS

Titles

No	Text
1	Glatiramer acetate & liposomal doxorubicin launch in us market a testimony of our skills in developing complex products
2	The product now launched heralds a breakthrough in affordability and cure for millions
3	At natco we manufacture niche and complex pharma products under the pressure of expectation
4	The need of society creates a global demand for affordable drugs, which we are focused on meeting
5	We deliver finished formulation and apıs from award winning facilities while improving our r&d and discovery pipeline
6	We continue to pioneer the ındian oncology market and expect more niche brand formulations to be launched

No	Text
1	About
2	Blockbusters
3	Product offerings
4	Natco trust
5	ınvestors
6	Careers
7	Contact

No	Text
1	Latest news & announcements
2	Corporate vıdeos
3	Awards

Text Styling

STRONG0
B0
EM0
I0
U0
CITE0

LINK ANALYSIS

Total Link Count: 84

Internal Link Count : 81

No	Text	Type
1	Home	text
2	Our Business	text
3	About	text
4	Mission & Heritage	text
5	Values	text
6	Management	text
7	Facilities	text
8	News & Announcements	text
9	Innovation	text
10	Analytical	text
11	Generic Research	text
12	Intellectual Property	text
13	New Drug Discovery	text
14	Opportunities	text
15	Markets	text
16	India	text
17	International	text
18	Investors	text
19	Financials	text
20	financials	text
21	Subsidiary Accounts	text
22	Stocks	text
23	Shareholder Information	text
24	Shareholding Pattern	text
25	Investor Presentation	text
26	Statutory Communications	text
27	Scheme of Amalgamation	text
28	Unclaimed Dividend	text
29	Investors Education Protection Fund (IEPF)	text
30	Buy back	text
31	PAPER ADVERTIs*****TS	text
32	Board Meeting Intimations	text
33	Annual Reports	text
34	Corporate Governance & Policies	text
35	Corporate Governance Certificate	text
36	IR and Shareholder Contacts	text
37	QIP 2017	text
38	People	text
39	Meet Our People	text
40	Careers	text
41	Responsibility	text
42	CSR Policy	text
43	Environment, Health & Safety	text
44	Attivaram	text
45	Certification & Awards	text
46	Natco Trust	text
47	Business Responsibility Policies	text
48	Sustainability Report	text
49	Contact	text
50	Locations	text